A tale of two countries: Attempts to control HIV among injecting drug users in Australia and the United States

Journal of Drug Issues

Volumn 27, Issue 1, 1997, Pages 117-134

  Wodak, Alex ^a   Lurie, Peter ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; AUSTRALIA; HEALTH EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION CONTROL; INSTRUMENT STERILIZATION; INTRAVENOUS DRUG ABUSE; METHADONE TREATMENT; NEEDLE; UNITED STATES;

EID: 0030910491     PISSN: 00220426     EISSN: None     Source Type: Journal    
DOI: 10.1177/002204269702700108     Document Type: Article

References (60)

1. Blewett, N. 1987 National Campaign Against Drug Abuse: Assumptions, Arguments, and Aspirations. Canberra:Australian Government Publishing Service, NCADA Monograph Number 1.
2. Burris S., D. Finucane, H. Gallagher, J. Grace 1996 The legal strategies used in operating syringe exchange programs in the United States. American Journal of Public Health 86:1161-1166.
3. Caplehom, J.R.M., and M.W. Ross 1995 Methadone maintenance and the likelihood of risky needle sharing. IntemationalJournal of Addiction 30(6):685-698.
4. Centers for Disease Control 1990 Risk behavior for HTV transmission among intravenous drug users not in treatment - United States, 1987-1989. Morbidity Mortality Weekly Report 39:273-276.
5. Chitwood, D.D. 1994 HTV risk and injection drug users - evidence for behavioral change. American Journal of Public Health 84:350, annotation.
6. Choi, K.H., and T.J. Coates 1994 Prevention of HTV infection. AIDS 8:1371-89, editorial.
7. Commonwealth Department of Community Services and Health 1989 National HIV/AIDS Strategy. A Policy Information Paper. Canberra:Australian Government Publishing Service.
8. Commonwealth Department of Health and Family Services 1996 Partnership in Practice: National HIV/AIDS strategy 1996-97 to 1998-99. CanberrarAustralian Government Publishing Service.
9. Crofts, N., D. Jolly, J. Kaldor, I. van Beek, and A. Wodak n.d. The epidemiology of hepatitis C virus infection among injecting drug users in Australia. Journal of Epidemiology and Community Health, in press.
10. Crofts, N., T. Stewart, P. Heame, X.Y. Ping, A.M. Breschkin, and S.A. Locarnini 1995 Spread of blood borne viruses among Australian prison entrants. British Medical Journal 310:285-288.
11. Curran, J.W., L.W. Scheckel, and R.A. Mllstein 1993 HIV/AIDS Prevention Bulletin. April 19.
12. D'Aunno, T., and T.E. Vaughn. 1992 Variations in methadone treatment practices: Results from a national study. Journal of the American Medical Association 267:253-258.
13. Department of Human Services and Health 1994 Statistics on drug abuse in Australia 1994. Canberra:Australian Government Publishing Service.
14. Des Jarlais, D.C., and S.R. Friedman 1990 The epidemic of HTV among injecting drug users in New York City: the first decade and possible future directions. In AIDS and Drug Misuse: the Challenge for Policy and Practice in the 1990s eds. J Strang GV Stimson London. Routledge.
15. Des Jarlais, D.C., S.R. Friedman, D. Novick, J.L. Sotheran, P Thomas, S.R. Yankovitz, D. Mildvan, J. Weber, M.J. Kreek, R. Maslansky, S. Bartelme, T. Spira, and M. Marmor 1989 HIV-1 infection among intravenous drug users in Manhattan, from 1977 through 1987. Journal of the American Medical Association 261: 1008-1012.
16. Des Jarlais, D.C., H. Hagan, S.R. Friedman, P. Friedmann, D. Goldberg, M. Frischer, S. Green, K. Tunving, B. Ljunberg, A. Wodak, M. Ross, D. Purchase, M.E. Milson, and T. Myers 1995 Maintaining low HIV seroprevalence in populations of injecting drug users. Journal of the American Medical Association 274:1226-1231.
17. Feachem, R.G.A. 1995 Valuing the past...investing in the future. Evaluation of the national HIV/AIDS strategy 1993-94 to 1995-96. Canberra:Australian Government Publishing Service, Commonwealth Department of Human Services and Health.
18. Friedman, S.R., W. de Jong, and A. Wodak 1993 Community development as a response to HIV among drug injectors. AIDS 7(suppl. 1):S263-S269.
19. Gerberding, J.L. 1995 Drug therapy: Management of occupational exposures to blood-borne viruses. New England Journal of Medicine 332:444-451.
20. Gostin, L.O., Z. Lazzarini, and K.M. Flaherty 1996 Limitations on the sale and possession of syringes; results of a national survey of law and regulations. Centers for Disease Control and Prevention, Atlanta.
21. Groseclose, S.L., B. Weinstein, T.S. Jones, L.A. Valleroy, L.J. Fehrs, and W.J. Kassler 1995 Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers -Connecticut, 1992-1993. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10:82-89.
22. Hagan, H., D.C. Des Jarlais, S.R. Friedman, D. Purchase, and M.J. Alter 1995 Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. American Journal of Public Health 85:1531-7.
23. Henry J. Kaiser Family Foundation 1996 The Kaiser survey on Americans andAlDS/HIV. Menlo Park, March 26.
24. Holmberg, S.D. 1996 The estimated prevalence and incidence of HTV in 96 large U.S. metropolitan areas. American Journal of Public Health 86:642-654.
25. Hurley. S, D. Jolley, and J. Kaldor 1996 An economic evaluation of aspects of the Australian HIV/AIDS strategies. Canberra:Australian Government Publishing Service, 56-60.
26. Kahn, J.G. 1993 Are NEPs cost-effective in preventing HTV infection? In Tlie public health impact of needle exchange programs in the United States and abroad, vol. I, eds. P. Lurie, A.L. Reingold, B. Bowser, D. Chen, J. Foley, J. Guydish, J.G. Kahn, S. Lane, and J. Sorenson. San Francisco: University of California.
27. Kaldor, J., J. Elford, A. Wodak, J.N. Crofts, and S. Kidd. 1993 HTV prevalence among IDUs in Australia: A methodological review. Dnig and Alcohol Review 12:175-184.
28. Keys Young 1995 Review of NSW needle and syringe exchange program. Sydney, draft report.
29. Lane, S. 1993 How and why did NEPs develop? In The Public Health Impact of Needle Exchange Programs in the United States and abroad, vol. I, eds. P. Lurie, A.L. Reingold, B. Bowser, D. Chen, J. Foley, J. Guydish, J.G. Kahn, S. Lane, and J. Sorenson. San Francisco:University of California.
30. Lenton, S. 1994 Illicit drug use, harm reduction and the community: attitudes to cannabis la\v and needle and syringe provision in Western Australia. Per//;:National Centre for Research into the Prevention of Drug Abuse, technical report.
31. Loxley, W., S. Carruthers, and J. Bevan 1995 In the same vein. First report of the Australian study of HIV and injecting dnig use (ASHIDU). Perth:National Centre For Research into the Prevention of Drug Abuse.
32. Lune, P., and E. Drucker 1996 An opportunity lost: Estimating the number of HIV associated with the U.S. Government opposition to needle exchange programs. Presented at XI International Conference on AIDS, Vancouver, July 7-12, oral presentation Tu.C.324.
33. Lurie, P., A.L. Reingold, B. Bowser, D. Chen, J. Foley, J. Guydish, J.G. Kahn, S. Lane, and J. Sorenson, eds. 1993 Tfie public health impact of needle exchange programs in the United States and abroad, vol. I. San Francisco:University of California.
34. Makkai, T. 1994 Patterns of drug use: Australia and the United States. Canberra: Australian Government Publishing Service.
35. National Centre For Epidemiology And Clinical Research 1995a Australian HIV Surveillance Report. 11 (2): 14, April.
36. National Centre For Epidemiology And Clinical Research 1995b Australian HIV Surveillance Report. 11(4):17, October.
37. National Commission on Acquired Immune Deficiency Syndrome 1991 The tivin epidemics of substance use andHlV. Washington, D.C.
38. National Research Council and Institute of Medicine 1995 Preventing HIV transmission. The role of sterile needles and bleach. Washington, D.C.:National Academy Press.
39. Office of Technology Assessment 1995 The effectiveness of AIDS prevention efforts. Washington,- D.C.
40. Paone, D., D.C. Des Jarlais, J. Clark, et al. 1995 Syringe exchange programs - United States, 1994-1995. Morbidity and Mortality Report 44:684-685.
41. Rettig, R.E., and A. Yarmolinsky, eds. 1995 Federal regulation of methadone treatment. Washington, D.C.:National Academy Press, Institute of Medicine.
42. Review Working Party n.d. A Review of needle exchange in NSW. Sydney:NSW Department of Health, forthcoming.
43. Sarkar, S., N. Das, S. Panda, T.N. Naik, K. Sarkar, B.C. Singh, J.M. Ralte, S.M. Aier, and S.P. Tripathy 1993 Rapid spread of HTV among injecting drug users in Northeastern states of India. Bulletin on Narcotic Dnigs XLV:91.
44. Satcher, D. 1993 Note to Jo Ivey Boufford, December 10. Available from the Drug Policy Foundation, 4455 Connecticut Avenue, N.W., Suite B-500, Washington, D.C., 20008.
45. Schwartz, J. 1995 Reports back needle exchange programs. Washington Post, February 16, p. A6.
46. Schwartzkopf, J., S. Spooner, B. Flaherty, J. Braw, A. Grimsley, K. Scanlon, and Kk Stewart 1990 Community attitudes to needle and syringe exchange and to methadone programs. Sydney :NS W Department of Health, A 90/6.
47. Stimson, G.V. 1995 AIDS and injecting drug use in the United Kingdom, 1987-1993: Thepolicy response and the prevention of the epidemic. Social Science and Medicine 41:699-716.
48. Stimson, G.V. 1996 Has the United Kingdom averted an epidemic of HTV-1 infection amongst drug injectors? Addiction 91(8):1085-1088, editorial.
49. Taylor, R., and G. Salkeld 1996 Health care expenditure and life expectancy in Australia: How well do we perform? Australian and New Zealand Journal of Public Health 20(3): 233-240.
50. U.S. General Accounting Office 1993 Needle exchange programs: Research suggests promise as an AIDS prevention strategy. Washington, D.C.:U.S. Government Printing Office Report Number GAO/HRD-93-60.
51. Ward, J., R. Mattick, and W. Hall 1992 Key issues in methadone maintenance treatment. Sydney:University of New South Wales Press.
52. Weinberg, D.S., and H.W. Murray 1987 Coping with AIDS-the special problems of New York City. New England Journal of Medicine 317:1469-1473.
53. Weniger, E.G., K. Limpakarnjanarat, K. Ungchusak, S. Thanprasertsuk, K. Choopanya, S. Vanichseni, T. Uneklabh, P. Thongcharoen, and C. Wasi 1991 The epidemiology of HP/ infection and AIDS in Thailand. AIDS 5 (suppl. 2):S71-S85.
54. Wiley, J., and M. Samuel 1989 Prevalence of HTV infection in the USA. AIDS 3 (suppl. l):71-78.
55. Wodak, A. 1992 HIV infection and injecting drug use in Australia: Responding to a crisis. Journal of Drug Issues 22(3):549-562.
56. Wodak, A., and N. Crofts 1996 Once more unto the breach: Controlling hepatitis C in injecting drug users. Addiction 91(2):181-184, editorial.
57. Wodak, A., A. Stowe, K. Dolan, M.W. Ross, and J. Gold n.d. Characteristics and risk behaviours of injecting drug users attending needle exchange programs and pharmacies. Forthcoming.
58. Wolk, J., A. Wodak, J. Guinan, P. Macaskill, and J.M. Simpson 1990 The effect of a needle and syringe exchange on a methadone maintenance unit. British Journal of Addiction 85:1445-1450.
59. World Bank 1993 World Development Report 1993. Investing in Health. Oxford:Oxford University Press, 239, published for the World Bank.
60. World Health Organisation 1994 Multi-city study of drug injecting and risk of HIV infection. Geneva, A report prepared on behalf of the WHO International Collaborative Group.